Compare RYM & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYM | LNSR |
|---|---|---|
| Founded | 2016 | 2004 |
| Country | United States | United States |
| Employees | 141 | N/A |
| Industry | Farming/Seeds/Milling | Medical Electronics |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.2M | 69.1M |
| IPO Year | N/A | 2005 |
| Metric | RYM | LNSR |
|---|---|---|
| Price | $21.28 | $5.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 8.7K | ★ 110.0K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $58,435,000.00 |
| Revenue This Year | N/A | $10.06 |
| Revenue Next Year | N/A | $41.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $14.00 | $5.06 |
| 52 Week High | $53.65 | $13.32 |
| Indicator | RYM | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 38.17 | 46.81 |
| Support Level | $20.76 | $5.58 |
| Resistance Level | $28.48 | $6.20 |
| Average True Range (ATR) | 1.05 | 0.24 |
| MACD | -0.16 | -0.03 |
| Stochastic Oscillator | 21.73 | 13.44 |
Rythm Inc is a USA Based company. The company's portfolio of brands delivers well-being to millions of Americans every year. The company features some of the recognized and trusted names in the cannabis and hemp industries, including RYTHM, incredibles, Dogwalkers, Beboe, Senorita THC Margaritas, &Shine, Doctor Solomon's and Good Green in thousands of physical locations and online channels. With products rooted in quality, safety, and innovation, the Company is shaping cannabis experiences that enhance daily life.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.